4//SEC Filing
Lisby Steen 4
Accession 0001104659-23-008009
CIK 0001722964other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:35 PM ET
Size
13.1 KB
Accession
0001104659-23-008009
Insider Transaction Report
Form 4
Lisby Steen
Sr VP & CMO
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-26+32,000→ 32,000 totalExercise: $4.55Exp: 2033-01-26→ Common stock (32,000 underlying)
Footnotes (2)
- [F1]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F2]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 26, 2024, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting.
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001753152
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:35 PM ET
- Size
- 13.1 KB